Although not statistically significant, there was an observed trend in which CAB + RPV Q8W had a numerically higher risk of resistance compared with all INSTI‐based STRs and CAB + RPV Q4W.
← all excerpts
Comparison of treatment-emergent resistance-associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor-based single-tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta-analysis.
1
—
—